Accelerated Aging Disease Focuses on Potential New Therapeutic Target

The devastating effects of rare disorders are no more felt than those suffering from the autosomal dominant genetic disease commonly referred to as progeria—formally known as Hutchinson-Gilford progeria syndrome (HGPS)—which is characterized by premature aging. Now, investigators from the University of Cambridge have identified a potential therapeutic target, which they have shown leads to significant health and lifespan gains in a mouse model of HGPS. Findings from the new study wer